{
    "SPADE_UN_13993": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13993",
            "Peptide Name": "P23(derived from E2 envelope protein of GB virus C)",
            "Source": "Synthetic construct(derived from E2 envelope protein of GB virus C)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "PITHWSHGQNRWPLSCPQ",
            "Sequence Length": 18,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=508.8 μM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C96H138N30O25S",
            "Mass": 2144.37,
            "PI": 8.68,
            "Net Charge": 3,
            "Hydrophobicity": -1.11,
            "Half Life": "Mammalian:>20 hourYeast:>20 hourE.coli:?",
            "Mechanism of action": "E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",
            "Literature": [
                {
                    "Title": "Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.",
                    "Pubmed ID": "20718496",
                    "Reference": "J Med Chem. 2010 Aug 26;53(16)6054-63.",
                    "Author": "Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=20718496"
                },
                {
                    "Title": "Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection",
                    "Pubmed ID": "",
                    "Author": "Herrera E, Tenckhoff S, Gomara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, H"
                }
            ],
            "Frequent Amino Acids": "PHQ",
            "Absent Amino Acids": "ADEFKMOUVY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 10,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13990",
                    "Similarity": 1.0,
                    "Sequence": "LPAFCQAIGWGDPITHWS"
                },
                {
                    "SPADE_ID": "SPADE_UN_13991",
                    "Similarity": 1.0,
                    "Sequence": "FCQAIGWGDPITHWSHGQ"
                },
                {
                    "SPADE_ID": "SPADE_UN_13992",
                    "Similarity": 1.0,
                    "Sequence": "AIGWGDPITHWSHGQNRW"
                }
            ]
        }
    }
}